Belgian Pharma Stock News

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...

BNP Paribas Asset Management has disclosed crossing the 3% legal threshold of direct voting rights in Umicore. The disclosure reflects an increased stake that now exceeds the mandatory reporting level for shareholder voting power. Umicore (ENXTBR:UMI) is trading at €18.8, with the share price up 81.3% over the past year, while longer term returns over 3 and 5 years show declines of 37.6% and 55.1% respectively. This mix of strong recent performance and weaker multi year returns gives a...

Econocom Group (ENXTBR:ECONB) closed FY 2025 with second half revenue of €1.5b and net income from continuing operations of €34.5m, while trailing twelve month net income from continuing operations reached €53.2m. The company has seen half year revenue move from €1.4b in H2 2024 to €1.5b in H2 2025, with trailing twelve month revenue rising from €2.7b to €2.9b over the same comparison window. With net profit margins running at 1.8% over the last year and earnings growth expectations in focus,...

Why Anheuser-Busch InBev (ENXTBR:ABI) is on investors’ radar Anheuser-Busch InBev (ENXTBR:ABI) has attracted attention after a period of solid share price gains, with the stock showing positive returns over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Anheuser-Busch InBev. For context, Anheuser-Busch InBev’s share price has climbed to €64.86, with a 30-day share price return of 13.63% and a 1-year total shareholder return of 31.08%, which...

Let's talk about the popular D'Ieteren Group SA ( EBR:DIE ). The company's shares received a lot of attention from a...

Melexis (ENXTBR:MELE) is back in focus after releasing its Q4 and full year 2025 results, with quarterly figures pointing one way and the full year picture pointing another for revenue and earnings. See our latest analysis for Melexis. The earnings release appears to have sparked a short term reaction, with a 1 day share price return of 3.05% taking Melexis to €57.4. However, the 30 day share price return of an 8.67% decline and 1 year total shareholder return of 7.18% suggest only modest...

Key Insights Elia Group's significant private companies ownership suggests that the key decisions are influenced by...

It's been a good week for Lotus Bakeries NV ( EBR:LOTB ) shareholders, because the company has just released its latest...

As the European market continues to show resilience, with the STOXX Europe 600 Index reaching new highs, optimism around the eurozone economy is buoying investor sentiment despite recent volatility. In such a climate, investors often look beyond traditional stocks to explore opportunities in less conventional areas like penny stocks. Although considered an outdated term, penny stocks still represent an intriguing investment avenue for those focusing on smaller or newer companies that may...

If you have been wondering whether Anheuser-Busch InBev shares are offering good value at current levels, this article walks through what the numbers are actually saying about the stock. The share price recently closed at US$63.66, with reported returns of 4.2% over 7 days, 12.6% over 30 days, 17.0% year to date, 32.3% over 1 year, 20.1% over 3 years, and 23.4% over 5 years. These figures provide useful context before assessing what the business might be worth. Recent coverage around...

VLCC sale puts fresh focus on Cmb.Tech (ENXTBR:CMBT) Cmb.Tech (ENXTBR:CMBT) has attracted renewed attention after agreeing to sell its two VLCC vessels, Ingrid and Ilma. Delivery is scheduled for Q2 2026, with an expected capital gain of about US$98.2 million. See our latest analysis for Cmb.Tech. The VLCC sale headlines come as Cmb.Tech’s share price has moved to €10.66, with a 30 day share price return of 9.78% and a 90 day gain of 28.43%. The 5 year total shareholder return of 123.89%...

Lotus Bakeries (ENXTBR:LOTB) has wrapped up FY 2025 with second half revenue of €697.7 million, basic EPS of €114.31 and net income of €92.9 million, while trailing twelve month revenue sits at about €1.4 billion with EPS of €212.06. The company has seen revenue move from €632.7 million in the second half of 2024 to €657.3 million in the first half of 2025 and €697.7 million in the second half of 2025. EPS over the same periods stepped from €99.12 to €97.74 and then €114.31, setting up a...

Key Insights Significant control over Groupe Bruxelles Lambert by private companies implies that the general public has...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Umicore fair value estimate is €29.83 Umicore's €19.68 share...

It's been a sad week for Melexis NV ( EBR:MELE ), who've watched their investment drop 16% to €53.25 in the week since...

If you are wondering whether SCR-Sibelco is attractively priced right now, this article walks through how its current share price stacks up against a few different valuation checks. The stock last closed at €4,700.00, with returns of a 2.1% decline over 7 days, a 13.8% decline over 30 days, a 13.8% decline year to date and a 6.0% decline over the past year, which may have some investors reassessing both risk and opportunity around the shares. Recent moves in the share price sit against a...

Orange Belgium (ENXTBR:OBEL) FY 2025 Earnings Snapshot Orange Belgium (ENXTBR:OBEL) has just reported its FY 2025 numbers with first half revenue of €962.7 million and basic EPS of €0.04, alongside trailing 12 month revenue of €1.96 billion and EPS of €0.61 that frame the latest run rate. The company recorded revenue of €977.5 million in the first half of 2024 and €1,016.2 million in the second half of 2024, while EPS moved from a loss of €0.20 to a profit of €0.56, before landing at €0.04 in...

Why Lotus Bakeries Stock Is in Focus After Its 2025 Results Lotus Bakeries (ENXTBR:LOTB) is back on investors' radar after reporting full year 2025 earnings, including higher sales, net income and earnings per share, helped by its Natural Foods division and new capacity in Thailand. See our latest analysis for Lotus Bakeries. Investors have responded to the 2025 results and the Thailand and India growth plans with a 21.10% 1 month share price return and a 39.87% 3 month share price return,...

Melexis NV ( EBR:MELE ) has announced that it will pay a dividend of €1.68 per share on the 21st of May. This makes the...

Argenx's Vyvgart is significantly outperforming expectations, with recent sales figures pointing to stronger than anticipated demand. The company is preparing for major Phase 3 trial readouts that are expected to clarify the potential of its broader pipeline. These developments are drawing attention from healthcare investors who view Vyvgart as an important contributor to fund performance. argenx (ENXTBR:ARGX) is drawing fresh interest as Vyvgart's performance adds weight to its current...

Key Insights Banqup Group's significant individual investors ownership suggests that the key decisions are influenced...

Despite an already strong run, DEME Group NV ( EBR:DEME ) shares have been powering on, with a gain of 26% in the last...

UCB has received European Union approval for Kygevi to treat thymidine kinase 2 deficiency (TK2d) in patients whose disease began before age 12, marking the first EU-authorized therapy for this rare genetic condition. The decision builds on prior FDA approval and retrospective data showing a very large reduction in risk of death versus untreated TK2d patients, underscoring Kygevi’s medical significance for a small but highly underserved population. We’ll now examine how Kygevi’s first-in-EU...

In recent days, analysts have reiterated positive views on KBC Group, emphasizing its strong profitability, solid capital ratios, and ongoing dividends and buybacks. What stands out is how KBC’s conservative risk approach and continued investment in digital transformation are being framed as core strengths by the analyst community. We’ll now examine how this renewed focus on KBC’s disciplined capital returns shapes the company’s broader investment narrative. Rare earth metals are the new...